South Africa Receives First Lenacapavir HIV Prevention Doses

South Africa has received its first shipment of Lenacapavir, a groundbreaking twice-yearly injection for HIV prevention, marking a pivotal advancement in the nation's efforts to curb the epidemic. The 37,920 doses arrived at OR Tambo International Airport in Johannesburg last week via two consignments from Dublin, Ireland, on March 30 and April 2.

The injectable, known as pre-exposure prophylaxis or PrEP, targets high-risk individuals by inhibiting the HIV capsid protein, which is crucial for the virus to replicate and establish infection. Unlike daily oral pills, Lenacapavir requires administration only every six months, addressing common adherence challenges that affect many users. Health officials anticipate it will significantly boost prevention uptake, particularly among those who struggle with consistent daily medication.

Health Minister Aaron Motsoaledi hailed the arrival as a transformative step. "This is a groundbreaking moment in our ongoing fight against HIV and AIDS," he said. "The arrival of Lenacapavir gives us a powerful new tool to protect those most at risk and to reduce new infections across the country." He emphasized its potential for high compliance, noting,...